https://charts.traderzeitung.de/phases/US0352551081 string(1439) "{"isin":"US0352551081","name":"Anika Therapeutics Inc","stock_id_xnas":7873207,"stock_id_xnys":null,"generated_at":"2026-08-09 10:07:00","days":[{"date":"2026-08-05","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":19.2,"close_at":"2026-08-05 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":19.33,"close_at":"2026-08-05 22:30:00","complete":true,"perf_pct":0.6771}]},{"date":"2026-08-06","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":20.14,"close_at":"2026-08-06 21:59:00","complete":true,"perf_pct":4.1904},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":19.85,"close_at":"2026-08-06 22:03:00","complete":true,"perf_pct":-1.4399}]},{"date":"2026-08-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":21.475,"close_at":"2026-08-07 21:59:00","complete":true,"perf_pct":8.1864},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"

Anika Therapeutics Aktie News & Nachrichten

[WKN: 889120 | Symbol: ANIK]

Realtimekurs

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

10J

Alles

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Anika Therapeutics gefunden werden.

Anika Therapeutics Nachrichtenticker öffnen

MT Newswires 30.07.2026 16:30 Uhr

Research-Alert: B. Riley passt Kursziel für Anika Therapeutics von 18 auf 21 US-Dollar an, belässt Buy-Rating

MT Newswires 30.07.2026 14:16 Uhr

Artikel aus der Redaktion der Trader-Zeitung

Research-Alert: B. Riley passt Kursziel für Anika Therapeutics von 18 auf 21 US-Dollar an, belässt Buy-Rating

Research-Alert: Barrington erhöht Kursziel für Anika Therapeutics von 17 $ auf 21 $, belässt Outperform-Rating